These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

170 related items for PubMed ID: 6342746

  • 1. Calcitonin, carcinoembryonic antigen and neuron-specific enolase in medullary thyroid carcinoma.
    Lloyd RV, Sisson JC, Marangos PJ.
    Cancer; 1983 Jun 15; 51(12):2234-9. PubMed ID: 6342746
    [Abstract] [Full Text] [Related]

  • 2. Combining serum calcitonin, carcinoembryonic antigen, and neuron-specific enolase to predict lateral lymph node metastasis in medullary thyroid carcinoma.
    Ye L, Zhou X, Lu J, Wang Y, Xie X, Zhang J.
    J Clin Lab Anal; 2020 Jul 15; 34(7):e23278. PubMed ID: 32141647
    [Abstract] [Full Text] [Related]

  • 3. Relationship of tissue carcinoembryonic antigen and calcitonin to tumor virulence in medullary thyroid carcinoma. An immunohistochemical study in early, localized, and virulent disseminated stages of disease.
    Mendelsohn G, Wells SA, Baylin SB.
    Cancer; 1984 Aug 15; 54(4):657-62. PubMed ID: 6378353
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Familial and sporadic medullary thyroid carcinoma: clinical and immunohistological findings.
    Ekblom M, Välimäki M, Pelkonen R, Jansson R, Sivula A, Franssila K.
    Q J Med; 1987 Nov 15; 65(247):899-910. PubMed ID: 2901773
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Oxyphil and squamous variants of medullary thyroid carcinoma.
    Dominguez-Malagon H, Delgado-Chavez R, Torres-Najera M, Gould E, Albores-Saavedra J.
    Cancer; 1989 Mar 15; 63(6):1183-8. PubMed ID: 2917321
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Medullary thyroid carcinoma in multiple endocrine neoplasia types 2A and 2B.
    O'Riordain DS, O'Brien T, Weaver AL, Gharib H, Hay ID, Grant CS, van Heerden JA.
    Surgery; 1994 Dec 15; 116(6):1017-23. PubMed ID: 7985081
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Disseminated calcitonin-poor medullary thyroid carcinoma in a patient with calcitonin-rich primary tumor.
    Ruppert JM, Eggleston JC, deBustros A, Baylin SB.
    Am J Surg Pathol; 1986 Jul 15; 10(7):513-8. PubMed ID: 2873751
    [Abstract] [Full Text] [Related]

  • 16. Neuron-specific enolase (NSE) as a tumour marker and comparative evaluation with carcinoembryonic antigen (CEA) in small-cell lung cancer.
    Adewole IF, Newlands ES.
    Med Oncol Tumor Pharmacother; 1987 Jul 15; 4(1):11-5. PubMed ID: 3037205
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Occurrence of calcitonin, somatostatin-like immunoreactivity, and carcinoembryonic antigen in two sisters suffering from familial thyroid medullary carcinoma.
    Bethge N, Ahuja S, Diel F.
    Exp Clin Endocrinol; 1986 Dec 15; 88(3):365-72. PubMed ID: 2881797
    [Abstract] [Full Text] [Related]

  • 19. Multiple endocrine neoplasia 2A due to a unique C609S RET mutation presents with pheochromocytoma and reduced penetrance of medullary thyroid carcinoma.
    Kinlaw WB, Scott SM, Maue RA, Memoli VA, Harris RD, Daniels GH, Porter DM, Belloni DR, Spooner ET, Ernesti MM, Noll WW.
    Clin Endocrinol (Oxf); 2005 Dec 15; 63(6):676-82. PubMed ID: 16343103
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.